Another study on double KO mice demonstrated that the reduction of dynamin 2 (DNM2) expression in MTM1–/y mice was enough to decrease the early XLMTM lethality as well as most hallmarks of the disease; it also increased the lifespan of mice [176]. Here, DNM2 is linked to X-linked myotubular myopathy.